Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Placebo Cohorts in Phase-3 MS Treatment Trials - Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data.
Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.
Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins.
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis.
Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
Cannabinoids control spasticity and tremor in a multiple sclerosis model.
Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: results of the PREMiSe pilot study.
Multiple sclerosis: basic knowledge and new insights in perioperative management.
Humoral mechanisms in T cell vaccination: induction and functional characterization of anti-lymphocytic autoantibodies.
Cortical excitability changes over time in progressive multiple sclerosis.
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.
Expression and activation of human endogenous retroviruses of the W family in blood cells and astrocytes: implications for the pathogenesis of multiple sclerosis.
Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis.
Impact of Repeated Topical-Loaded Manganese-Enhanced MRI on the Mouse Visual System.
The Implication of Vitamin D and Autoimmunity: a Comprehensive Review.
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.
Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis.
Fingolimod (FTY720) stimulates ca(2+)/calcineurin signaling in fission yeast.
Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.
Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients.
Patients' experiences of adapting to multiple sclerosis: a qualitative study.

Pages